The weekly litigation news digest is live. Subscribe now

IP Verse

Argenx competitive analysis

Loading summary...

Latest patents of Argenx opposed by its competitors

Explore Argenx's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 4, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3728328
Oct 23, 2024Bispecific Antigen Binding Construct2
EP3638696
Jun 26, 2024Use Of Anti Cd70 Antibody Argx-110 To Treat Acute Myeloid Leukaemia1
EP3087095
Aug 7, 2019Fcrn Antagonists And Methods Of Use1

Latest PTAB cases involving Argenx

Discover the latest PTAB cases involving Argenx, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Argenx with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 4, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ARGENX BVBA - 4 - -
PFIZER51944312
SANOFI5923 - -
SIMMONS & SIMMONS7 - - -